Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 163

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis

Noseworthy, J. H., O’Brien, P. C., Petterson, T. M., Weis, J., Stevens, L., Peterson, W. K., Sneve, D., Cross, S. A., Leavitt, J. A., Auger, R. G., Weinshenker, B. G., Dodick, D. W., Wingerchuk, D. M., Rodriguez, M. · 2001 · Neurology

Abstract

OBJECTIVE: To determine whether IV immunoglobulin (IVIg) reverses chronic visual impairment in MS patients with optic neuritis (ON). METHODS: In this double-blind, placebo-controlled Phase II trial, 55 patients with persistent acuity loss after ON were randomized to receive either IVIg 0.4 g/kg daily for 5 days followed by three single infusions monthly for 3 months, or placebo. RESULTS: The trial was terminated by the National Eye Institute because of negative results when 55 of the planned 60 patients had been enrolled. Fifty-two patients completed the scheduled infusions, and 53 patients completed 12 months of follow-up. Analysis of this data indicated that a difference between treatment groups was not observed for the primary outcome measure, improvement in logMAR visual scores at 6 months (p = 0.766). Exploratory secondary analyses suggested that IVIg treatment was associated with improvement in visual function (including logMAR visual scores at 6 months and visual fields at 6 and 12 months) in patients with clinically stable MS during the trial. CONCLUSIONS: IVIg administration does not reverse persistent visual loss from ON to a degree that merits general use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.56.11.1514

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 163

Metadata

Authors
Noseworthy, J. H., O’Brien, P. C., Petterson, T. M., Weis, J., Stevens, L., Peterson, W. K., Sneve, D., Cross, S. A., Leavitt, J. A., Auger, R. G., Weinshenker, B. G., Dodick, D. W., Wingerchuk, D. M., & Rodriguez, M.
Venue
Neurology
Published
2001-06-12
Volume
56
Issue
11
Pages
1514-1522
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2158689288
Cited by
163
References
3
FWCI
7.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. https://app.cochat.ai/papers/10.1212/wnl.56.11.1514
The paper
Noseworthy, J. H., O’Brien, P. C., Petterson, T. M., Weis, J., Stevens, L., Peterson, W. K., Sneve, D., Cross, S. A., Leavitt, J. A., Auger, R. G., Weinshenker, B. G., Dodick, D. W., Wingerchuk, D. M., & Rodriguez, M. (2001). A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology. https://doi.org/10.1212/wnl.56.11.1514

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.